Jan. 23, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of Nimble Therapeutics. With the completion of the acquisition, Nimble is now a part of AbbVie.
SINGAPORE – Singapore’s approach towards greater artificial intelligence (AI) adoption is to be nimble and flexible, while ensuring that developments in the space take place within the limits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback